These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10532097)
1. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia]. Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS Vopr Onkol; 1999; 45(4):387-92. PubMed ID: 10532097 [TBL] [Abstract][Full Text] [Related]
2. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160 [TBL] [Abstract][Full Text] [Related]
3. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON). Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916 [TBL] [Abstract][Full Text] [Related]
5. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase. O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553 [TBL] [Abstract][Full Text] [Related]
6. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses. Peñarrubia MJ; Odriozola J; González C; Massagué I; Miguel A; González San Miguel JD; Pérez Encinas M; Lavilla E; Giraldo MP; Casado LF; Ferrer S; Steegmann JL; Ann Hematol; 2003 Dec; 82(12):750-8. PubMed ID: 14517691 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea. Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H; Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239 [TBL] [Abstract][Full Text] [Related]
8. [Interferon alpha--the drug of choice for patients with chronic myeloid leukemia]. Klamová H; Vítek A; Michalová K; Brezinová J; Moravcová J; Jelínek J; Cermák J Cas Lek Cesk; 1998 Sep; 137(18):552-6. PubMed ID: 9818464 [TBL] [Abstract][Full Text] [Related]
9. Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation. J Clin Oncol; 1999 Jun; 17(6):1858-68. PubMed ID: 10561226 [TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha in the treatment of patients with chronic myeloid leukemia]. Faber E; Jarosová M; Divoký V; Luhový M; Komenda S; Sulovská I; Hubácek J; Slezák P; Papajik T; Raida L; Heczko M; Indrák K Vnitr Lek; 1997 Jan; 43(1):13-7. PubMed ID: 9221559 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase. Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830 [TBL] [Abstract][Full Text] [Related]